Literature DB >> 25206994

Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles.

Ozlem Gün Eryılmaz1, Esma Sarıkaya1, Fatma Nur Aksakal2, Sevtap Hamdemir1, Muammer Doǧan1, Leyla Mollamahmutoǧlu1.   

Abstract

OBJECTIVE: The gonadotropin-releasing hormone-agonist (GnRH-a) treatment during in vitro fertilization (IVF) sometimes causes a functional ovarian cyst during the administration period before gonadotropin stimulation, as an undesired event. The aim of this study was to analyze the effect of these cysts on the IVF outcomes.
MATERIAL AND METHODS: Out of 981 IVF cycles, 78 with ovarian cysts were retrospectively analyzed with respect to the demographic characteristics, hormonal outcomes, and fertilization, implantation and clinical pregnancy rates.
RESULTS: The metaphase II oocyte ratio, fertilization rate and percentage of high quality embryos (grade 1) were significantly higher in the cyst-negative group (p<0.0001; p<0.0001; p≤0.05). These same three parameters were also significantly higher in the cyst-aspirated group (p<0.01; p<0.05; p<0.05). Cyst diameters of the aspiration group were significantly higher (p<0.05). No statistically significant differences in implantation and clinical pregnancy rates were determined between the groups.
CONCLUSION: An ovarian cyst formation during the GnRH-a suppression period negatively affects oocyte quality. Cyst aspiration before gonadotropin stimulation does not improve the IVF outcome.

Entities:  

Keywords:  Ovarian cyst; gonadotropin-releasing hormone agonist; in vitro fertilization (IVF)

Year:  2012        PMID: 25206994      PMCID: PMC4115850          DOI: 10.5152/balkanmedj.2011.019

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  15 in total

1.  Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome.

Authors:  M D Keltz; E E Jones; A J Duleba; T Polcz; K Kennedy; D L Olive
Journal:  Fertil Steril       Date:  1995-09       Impact factor: 7.329

2.  Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.

Authors:  H S Qublan; Z Amarin; Y A Tahat; A Z Smadi; M Kilani
Journal:  Hum Reprod       Date:  2005-10-27       Impact factor: 6.918

3.  Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment.

Authors:  M M Biljan; L Lapensée; N G Mahutte; F Bissonnette; R Hemmings; S L Tan
Journal:  Fertil Steril       Date:  2000-11       Impact factor: 7.329

4.  The effects of baseline ovarian cysts on the clinical response to controlled ovarian hyperstimulation in an in vitro fertilization program.

Authors:  M D Hornstein; R L Barbieri; V A Ravnikar; P M McShane
Journal:  Fertil Steril       Date:  1989-09       Impact factor: 7.329

5.  Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction.

Authors:  G E Fiszbajn; R G Lipowicz; L Elberger; A Grabia; S D Papier; S P Brugo Olmedo; C F Chillik
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

6.  Ovarian cysts decrease the success of controlled ovarian stimulation and in vitro fertilization.

Authors:  S S Thatcher; E Jones; A H DeCherney
Journal:  Fertil Steril       Date:  1989-11       Impact factor: 7.329

7.  The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles.

Authors:  J M Jenkins; D W Davies; F Anthony; P Wood; S G Gadd; R H Watson; G M Masson
Journal:  Hum Reprod       Date:  1992-07       Impact factor: 6.918

8.  Follicle cyst formation following long-acting gonadotropin-releasing hormone analog administration.

Authors:  R Ron-El; A Herman; A Golan; A Raziel; Y Soffer; E Caspi
Journal:  Fertil Steril       Date:  1989-12       Impact factor: 7.329

9.  Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.

Authors:  D Feldberg; J Ashkenazi; D Dicker; A Yeshaya; G A Goldman; D Dicker; J A Goldman
Journal:  Fertil Steril       Date:  1989-01       Impact factor: 7.329

10.  Management of prestimulation ovarian cysts during assisted reproductive treatments: impact of aspiration on the outcome.

Authors:  Banu Kumbak; Semra Kahraman
Journal:  Arch Gynecol Obstet       Date:  2008-11-21       Impact factor: 2.344

View more
  4 in total

1.  HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study.

Authors:  Hong Zeng; Chen Zhang; Lei Zhang; Nenghui Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

2.  Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist.

Authors:  Hui Ji; Yan Su; Mianqiu Zhang; Xin Li; Xiuling Li; Hui Ding; Li Dong; Shanren Cao; Chun Zhao; Junqiang Zhang; Rong Shen; Xiufeng Ling
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

Review 3.  Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility.

Authors:  Rose McDonnell; Jane Marjoribanks; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2014-12-12

4.  Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.